2016

November 11, 2019

Cellmid Investor Briefing

November 11, 2019

Ikon Legal Action

November 11, 2019

Appendix 4C – quarterly

November 11, 2019

Transcript of Cellmid Investor Briefing Call

November 11, 2019

Cellmid Investor Presentation

November 11, 2019

New publication for Cellmid’s Midkine antibody

November 11, 2019

Appendix 4E and Preliminary Final Report

November 11, 2019

Appendix 4G – Corporate Governance Statement

November 11, 2019

Date of Annual General Meeting